We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$433B
AUM Growth
+$39.3B
Cap. Flow
+$6.99B
Cap. Flow %
1.61%
Top 10 Hldgs %
19.86%
Holding
3,573
New
35
Increased
2,384
Reduced
635
Closed
102

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.16B
2
HSY icon
Hershey
HSY
+$663M
3
LMT icon
Lockheed Martin
LMT
+$622M
4
MO icon
Altria Group
MO
+$525M
5
PFE icon
Pfizer
PFE
+$499M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$2.76B
2
MRK icon
Merck
MRK
+$2.35B
3
ADP icon
Automatic Data Processing
ADP
+$1.57B
4
BX icon
Blackstone
BX
+$1.38B
5
ITW icon
Illinois Tool Works
ITW
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 12.71%
3 Healthcare 11.72%
4 Consumer Discretionary 10.09%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UONE icon
3326
Urban One Class A
UONE
$22.8M
$82.2K ﹤0.01%
3,046
AQST icon
3327
Aquestive Therapeutics
AQST
$463M
$81.3K ﹤0.01%
19,078
BINI
3328
DELISTED
Bollinger Innovations
BINI
0
OPFI icon
3329
OppFi
OPFI
$800M
$80.6K ﹤0.01%
32,245
WNEB icon
3330
Western New England Bancorp
WNEB
$259M
$79.4K ﹤0.01%
10,349
RBOT
3331
DELISTED
Vicarious Surgical
RBOT
$78.6K ﹤0.01%
8,689
LVO icon
3332
LiveOne
LVO
$61.7M
$77.6K ﹤0.01%
3,979
HYPD
3333
Hyperion DeFi Inc
HYPD
$40M
$74.9K ﹤0.01%
949
BKKT icon
3334
Bakkt Inc
BKKT
$321M
$74.7K ﹤0.01%
6,497
-1,012
-13% -$27.2K
BDTX icon
3335
Black Diamond Therapeutics
BDTX
$96.8M
$73.4K ﹤0.01%
14,484
SACH
3336
Sachem Capital Corp
SACH
$39.1M
$72.9K ﹤0.01%
16,351
AXTI icon
3337
AXT Inc
AXTI
$3.95B
$72.9K ﹤0.01%
15,887
KOPN icon
3338
Kopin
KOPN
$652M
$72.3K ﹤0.01%
40,189
UPLD icon
3339
Upland Software
UPLD
$12.8M
$70.4K ﹤0.01%
2,278
MYO icon
3340
Myomo
MYO
$39M
$70.3K ﹤0.01%
+21,495
New +$77.9K
MPU icon
3341
Mega Matrix
MPU
$16.1M
$69.1K ﹤0.01%
24,173
CBIO
3342
Crescent Biopharma
CBIO
$537M
$67.1K ﹤0.01%
224
RNXT icon
3343
RenovoRx
RNXT
$43.2M
$66K ﹤0.01%
49,232
DZSI
3344
DELISTED
DZS Inc. Common Stock
DZSI
$65.8K ﹤0.01%
49,884
PHX
3345
DELISTED
PHX Minerals
PHX
$63.4K ﹤0.01%
18,580
CUTR
3346
DELISTED
Cutera, Inc.
CUTR
$62.3K ﹤0.01%
42,386
OKUR
3347
OnKure Therapeutics
OKUR
$154M
$62.3K ﹤0.01%
3,750
PYXS icon
3348
Pyxis Oncology
PYXS
$168M
$61.9K ﹤0.01%
+14,524
New +$61.1K
FREE
3349
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$61.7K ﹤0.01%
12,768
UONEK icon
3350
Urban One Class D
UONEK
$22.8M
$60.5K ﹤0.01%
2,966

Similar funds

Charles Schwab's Q1 2024 Portfolio in Review

As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
  • Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
  • Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
  • Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
  • Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.